[VRP] Implementing Vancomycin Reducing Protocols in Preterm Infants

logo for CRCU

Funding: Agency for Healthcare Research and Quality
Investigator: Mukhopadhyay, SM

The primary objective of the VRP study is to reduce unnecessary vancomycin use in preterm infants by implementing/re-enforcing VRP across multiple NICUs. Additional objectives of the study are to determine the effect of external facilitation on the fidelity of VRP use and to identify barriers and facilitators to implementation of the VRP across NICUs.

This project started in April 2024. The CRCU supports the study with project management and data management services.